SYVERSON STREGE & CO – Eli Lilly and Company Transaction History
SYVERSON STREGE & CO portfolio value:
$107,000
portfolio value
SYVERSON STREGE & CO quarter portfolio value change:
-0.27%
quarter
Eli Lilly and Company 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 0 | $323.35 | 330 | |
| Q2 2022 | share | 0.00% | 0 shares | 12K | $324.23 | 330 | |
| Q1 2022 | share | 0.00% | 0 shares | 4K | $286.37 | 330 | |
| Q4 2021 | share | Decrease | -26.67% | -120 shares | -13K | $277.25 | 330 |
| Q3 2021 | share | Increase | +36.36% | 120 shares | 28K | $230.3 | 450 |
| Q2 2021 | share | 0.00% | 0 shares | 14K | $228.04 | 330 | |
| Q1 2021 | share | 0.00% | 0 shares | 6K | $184.81 | 330 | |
| Q4 2020 | share | Increase | 0.00% | 330 shares | 56K | $166.32 | 330 |